Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS

被引:165
作者
Zagury, D
Lachgar, A
Chams, V
Fall, LS
Bernard, J
Zagury, JF
Bizzini, B
Gringeri, A
Santagostino, E
Rappaport, J
Feldman, M
Burny, A
Gallo, RC
机构
[1] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA
[2] Inst Jean Godinoi, F-51100 Reims, France
[3] Univ Pierre & Marie Curie, Paris, France
[4] Univ Milan, I-20122 Milan, Italy
[5] Maggiore Hosp, IRCCS, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Bologna, Italy
[6] Allegheny Univ Hlth Sci, Ctr Neurovirol & Neurooncol, Philadelphia, PA 19102 USA
[7] Univ Libre Bruxelles, B-1050 Brussels, Belgium
[8] Weizmann Inst Sci, IL-76100 Rehovot, Israel
关键词
D O I
10.1073/pnas.95.7.3851
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV type 1 (HIV-1) not only directly kills infected CD4(+) T cells but also induces immunosuppression of uninfected T cells, Two immunosuppressive proteins, interferon alpha (IFN alpha) and extracellular Tat, mediate this process because specific antibodies against these proteins prevent generation of suppressor cells in HIV 1-infected peripheral blood mononuclear cell cultures, Furthermore, the production of C-C chemokines in response to immune cell activation, initially enhanced by IFN alpha and Tat, ultimately is inhibited by these proteins in parallel with their induction of immunosuppression, The clinical corollary is the immunosuppression of uninfected T cells and the decline in C-C chemokine release found at advanced stages of HIV-1 infection paralleling rising levels of IFN alpha and extracellular Tat, We, therefore, suggest that IFN alpha and Tat may be critical targets for anti-AIDS strategies.
引用
收藏
页码:3851 / 3856
页数:6
相关论文
共 44 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] AMBRUS JL, 1989, AM J MED, V87, P405, DOI 10.1016/S0002-9343(89)80822-8
  • [3] AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
  • [4] ANDREESEN R, 1990, CANCER RES, V50, P7450
  • [5] The neglected role of type I interferon in the T-cell response: Implications for its clinical use
    Belardelli, F
    Gresser, I
    [J]. IMMUNOLOGY TODAY, 1996, 17 (08): : 369 - 372
  • [6] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [7] BROUTYBOYE D, 1981, CANCER RES, V41, P4174
  • [8] COORDINATE INDUCTION OF INTERFERON-ALPHA AND INTERFERON-GAMMA BY RECOMBINANT HIV-1 GLYCOPROTEIN-120
    CAPOBIANCHI, MR
    AMEGLIO, F
    FEI, PC
    CASTILLETTI, C
    MERCURI, F
    FAIS, S
    DIANZANI, F
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) : 957 - 962
  • [9] CD4(+) AND CD8(+) LYMPHOCYTES OF PATIENTS WITH AIDS SYNTHESIZE INCREASED AMOUNTS OF INTERFERON-GAMMA
    CARUSO, A
    CANARIS, AD
    LICENZIATI, S
    CANTALAMESSA, A
    FOLGHERA, S
    LONATI, MA
    DEPANFILIS, G
    GAROTTA, G
    TURANO, A
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (04): : 462 - 470
  • [10] IDENTIFICATION OF HUMAN CD4 RESIDUES AFFECTING CLASS-II MHC VERSUS HIV-1 GP120 BINDING
    CLAYTON, LK
    SIEH, M
    PIOUS, DA
    REINHERZ, EL
    [J]. NATURE, 1989, 339 (6225) : 548 - 551